Merck to support DEXA scanner sales

Article

Dual-energy x-ray absorptiometry firms Lunar and Hologic are gettinga boost from pharmaceutical giant Merck, which signed separatejoint financing agreements with the densitometry competitors topromote sales of their DEXA scanners in the U.S. Merck, of

Dual-energy x-ray absorptiometry firms Lunar and Hologic are gettinga boost from pharmaceutical giant Merck, which signed separatejoint financing agreements with the densitometry competitors topromote sales of their DEXA scanners in the U.S.

Merck, of West Point, PA, has developed Fosamax, a drug for thetreatment of osteoporosis that is close to receiving Food andDrug Administration approval. Merck hopes that the diffusion ofDEXA scanners will help fuel Fosamax sales when the drug becomesavailable. Merck estimates that there are 700 DEXA systems inclinical use in the U.S.

Under the agreements announced last week, Merck will assist infinancing the acquisition of DEXA scanners and will provide educationalprograms to increase awareness of bone mineral density testing.In Lunar's case, physicians will be able to acquire the Madison,WI, company's low-cost DPX densitometer on a fee-per-patient basis.Lunar's premium Expert system and its Achilles ultrasound productare not covered by the program.

Hologic will also provide its Acclaim fanbeam scanner on a fee-per-patientbasis, which reduces the initial investment needed to acquirecapital equipment. Physicians can withdraw from the program andreturn the equipment without penalty if there is no demand forDEXA services, Hologic said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.